Suppr超能文献

估算肾小球滤过率:是否足够好?是否到了该向前发展的时候?

Estimating glomerular filtration rate: is it good enough? And is it time to move on?

机构信息

University of California, San Francisco, San Francisco, California, USA.

出版信息

Curr Opin Nephrol Hypertens. 2013 May;22(3):310-5. doi: 10.1097/MNH.0b013e32836041e4.

Abstract

PURPOSE OF REVIEW

The aim is to examine a dominant narrative in nephrology over the past decade: that measured glomerular filtration rate (GFR) is the gold standard measure of kidney function; accurate assessment of GFR is critical and paramount; and further efforts to refine GFR estimation should continue.

RECENT FINDINGS

Studies that have simultaneously compared measured GFR and estimated GFR (using endogenous filtration markers such as creatinine, or newer ones such as cystatin C or β-trace protein) against some external metric of kidney function have failed to show that measured GFR is consistently superior, which is what one would expect if measured GFR were truly the 'gold standard.'

SUMMARY

Compared with estimated GFR, measured GFR does not consistently predict renal-related outcomes better. Clinical decision-making almost never requires precise and accurate knowledge of a patient's static GFR value. Efforts at perfecting cross-sectional estimates of GFR may have reached a point of diminishing returns.

摘要

审查目的

目的是检验过去十年肾脏病学中的一个主导性观点:即测量肾小球滤过率(GFR)是肾功能的金标准衡量指标;准确评估 GFR 至关重要;并且应该继续努力改进 GFR 估计。

最近的发现

同时比较了使用内源性滤过标志物(如肌酐)或更新的标志物(如胱抑素 C 或β-痕迹蛋白)测量的 GFR 与某些肾功能外部指标的研究未能表明测量的 GFR 始终具有优势,如果测量的 GFR 真的是“金标准”,那么这是人们所期望的。

总结

与估计的 GFR 相比,测量的 GFR 并不能始终更好地预测与肾脏相关的结局。临床决策几乎从不需要精确和准确地了解患者的静态 GFR 值。完善 GFR 横断面估计的努力可能已经达到了收益递减的地步。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验